The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.
Publication/Presentation Date
8-1-2016
Abstract
With the increasing number of individuals living with a current or prior diagnosis of cancer, it is important for the cardiovascular specialist to recognize the various complications of cancer and its therapy on the cardiovascular system. This is true not only for established cancer therapies, such as anthracyclines, that have well established cardiovascular toxicities, but also for the new targeted therapies that can have "off target" effects in the heart and vessels. The purpose of this informational statement is to provide cardiologists, cardiac imaging specialists, cardio-oncologists, and oncologists an understanding of how multimodality imaging may be used in the diagnosis and management of the cardiovascular complications of cancer therapy. In addition, this document is meant to provide useful general information concerning the cardiovascular complications of cancer and cancer therapy as well as established recommendations for the monitoring of specific cardiotoxic therapies.
Volume
23
Issue
4
First Page
856
Last Page
884
ISSN
1532-6551
Published In/Presented At
Russell, R. R., Alexander, J., Jain, D., Poornima, I. G., Srivastava, A. V., Storozynsky, E., & Schwartz, R. G. (2016). The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 23(4), 856–884. https://doi.org/10.1007/s12350-016-0538-8
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27251147
Department(s)
Administration and Leadership
Document Type
Article